HK1133248A1 - IRON (lll)-CARBOHYDRATE BASED PHOSPHATE ADSORBENT - Google Patents

IRON (lll)-CARBOHYDRATE BASED PHOSPHATE ADSORBENT

Info

Publication number
HK1133248A1
HK1133248A1 HK09111332.5A HK09111332A HK1133248A1 HK 1133248 A1 HK1133248 A1 HK 1133248A1 HK 09111332 A HK09111332 A HK 09111332A HK 1133248 A1 HK1133248 A1 HK 1133248A1
Authority
HK
Hong Kong
Prior art keywords
lll
iron
carbohydrate based
based phosphate
phosphate adsorbent
Prior art date
Application number
HK09111332.5A
Other languages
English (en)
Inventor
Michael Ambuehl
Corine Gessier-Vial
Christa Hartmann
Daniel Kaufmann
Ernst Kuesters
Ulrich Meier
Andreas Meyer
Nabila Sekkat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38983614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1133248(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06126122A external-priority patent/EP1932807A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1133248A1 publication Critical patent/HK1133248A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/223—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material containing metals, e.g. organo-metallic compounds, coordination complexes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/2803—Sorbents comprising a binder, e.g. for forming aggregated, agglomerated or granulated products
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/0018—Mixed oxides or hydroxides
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/02—Oxides; Hydroxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • External Artificial Organs (AREA)
HK09111332.5A 2006-12-14 2009-12-03 IRON (lll)-CARBOHYDRATE BASED PHOSPHATE ADSORBENT HK1133248A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06126101 2006-12-14
EP06126122A EP1932807A1 (en) 2006-12-14 2006-12-14 Inorganic compounds
PCT/EP2007/063832 WO2008071747A1 (en) 2006-12-14 2007-12-12 Iron (iii)-carbohydrate based phosphate adsorbent

Publications (1)

Publication Number Publication Date
HK1133248A1 true HK1133248A1 (en) 2010-03-19

Family

ID=38983614

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09111332.5A HK1133248A1 (en) 2006-12-14 2009-12-03 IRON (lll)-CARBOHYDRATE BASED PHOSPHATE ADSORBENT

Country Status (24)

Country Link
US (2) US8252310B2 (ko)
JP (1) JP5456969B2 (ko)
KR (1) KR20090094820A (ko)
AR (1) AR064301A1 (ko)
AU (1) AU2007331482B2 (ko)
BR (1) BRPI0720272A2 (ko)
CA (1) CA2671828C (ko)
CL (1) CL2007003606A1 (ko)
EC (1) ECSP099410A (ko)
ES (1) ES2526171T3 (ko)
HK (1) HK1133248A1 (ko)
IL (1) IL198548A0 (ko)
MA (1) MA30993B1 (ko)
MX (1) MX2009006307A (ko)
MY (1) MY151047A (ko)
NO (1) NO342285B1 (ko)
NZ (1) NZ576672A (ko)
PE (1) PE20081381A1 (ko)
PT (1) PT2319804E (ko)
RU (1) RU2447933C2 (ko)
SI (1) SI2319804T1 (ko)
TN (1) TN2009000214A1 (ko)
TW (1) TWI465239B (ko)
WO (1) WO2008071747A1 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
JP2009292119A (ja) 2008-06-09 2009-12-17 Alps Electric Co Ltd サーマルヘッド
EP2300153A2 (en) * 2008-06-13 2011-03-30 Novartis AG Manufacture process for the preparation of an iron containing phosphate adsorbent
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
CN109223724A (zh) * 2009-07-21 2019-01-18 凯克斯生物制药公司 柠檬酸铁剂型
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
DE102011112898A1 (de) 2011-09-08 2013-03-14 Charité - Universitätsmedizin Berlin Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen
CN103946019B (zh) * 2011-10-13 2016-10-05 维达西姆公司 铁-纤维组合物、其制备和用途
RU2496722C1 (ru) * 2012-04-10 2013-10-27 Леонид Асхатович Мазитов Способ очистки сточной воды от фосфатов
WO2014138016A1 (en) 2013-03-08 2014-09-12 Vidasym, Inc. Metal ion-functional fiber component complex compositions, preparation and uses thereof
US9339489B2 (en) * 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
CN109908355B (zh) * 2013-03-15 2022-11-15 阿普雷奇亚制药有限责任公司 包含左乙拉西坦的快速分散剂型
US10624855B2 (en) * 2013-11-27 2020-04-21 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical composition, comprising phosphate binder particles
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US9901918B2 (en) 2015-03-04 2018-02-27 Graver Technologies Llc Hybrid ion exchange material and method for making the same
CN105193844A (zh) * 2015-05-27 2015-12-30 合肥川迪医药技术有限公司 用于制备含δ-羟基氧化铁(多核)及其药物组合物的方法及在高磷血症领域中的应用
WO2017172633A1 (en) * 2016-03-28 2017-10-05 New Sky Energy Intellectual Property Holding Company, Llc Methods of producing ferrihydrite nanoparticle slurries, and systems and products employing the same
WO2020025552A1 (en) 2018-07-30 2020-02-06 Interquim, S.A. Process for preparing an adsorbent for phosphate in aqueous medium
AU2021208491A1 (en) * 2020-01-16 2022-08-18 Vifor Fresenius Medical Care Renal Pharma, Ltd. Particles of a mixture of iron(III)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide
CN115317494B (zh) * 2022-07-22 2024-02-13 康瑞鑫(天津)药物研究院有限公司 高磷酸盐结合力的蔗糖氢氧化氧铁及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885393A (en) * 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3697502A (en) * 1969-11-03 1972-10-10 Christensen Henry M Method of making iron dextran-preparations
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE3026868C2 (de) * 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
US4569836A (en) * 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
EP0330801A1 (en) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
SU1807606A1 (ru) * 1991-03-29 1995-08-09 Пермский политехнический институт Способ получения анионообменника на основе гидроксида титана
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
DE69320120T2 (de) 1992-09-04 1999-04-08 Mitsubishi Chemical Corp., Tokio/Tokyo Verfahren zur Herstellung und Verwendung eines Anionen- austauscherharzes
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
DE10128511A1 (de) * 2001-06-13 2002-12-19 Sebo Gmbh Verwendung eines Phosphatadsorbers gegen Gefäßerkrankungen
US20050107253A1 (en) * 2001-12-21 2005-05-19 Hiroyuki Sano Adsorbent for phosphoric acid
DE102004031181A1 (de) 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens

Also Published As

Publication number Publication date
NO20092632L (no) 2009-07-14
CL2007003606A1 (es) 2008-07-18
US20080145410A1 (en) 2008-06-19
ECSP099410A (es) 2009-07-31
MA30993B1 (fr) 2009-12-01
US8252310B2 (en) 2012-08-28
RU2447933C2 (ru) 2012-04-20
ES2526171T3 (es) 2015-01-07
PE20081381A1 (es) 2008-11-12
KR20090094820A (ko) 2009-09-08
JP2008150375A (ja) 2008-07-03
TN2009000214A1 (en) 2010-10-18
SI2319804T1 (sl) 2015-01-30
WO2008071747A1 (en) 2008-06-19
MX2009006307A (es) 2009-06-23
TWI465239B (zh) 2014-12-21
NO342285B1 (no) 2018-04-30
AU2007331482A1 (en) 2008-06-19
CA2671828A1 (en) 2008-06-19
PT2319804E (pt) 2014-11-24
TW200831115A (en) 2008-08-01
CA2671828C (en) 2012-06-19
US20120126440A1 (en) 2012-05-24
BRPI0720272A2 (pt) 2014-01-28
IL198548A0 (en) 2010-02-17
AR064301A1 (es) 2009-03-25
MY151047A (en) 2014-03-31
NZ576672A (en) 2012-02-24
RU2009126614A (ru) 2011-01-20
JP5456969B2 (ja) 2014-04-02
AU2007331482B2 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
HK1133248A1 (en) IRON (lll)-CARBOHYDRATE BASED PHOSPHATE ADSORBENT
PL2319804T3 (pl) Węglowodanowy adsorbent fosforanów oparty na żelazie (III)
ZA200902901B (en) Iron (III)-carbohydrate based phosphate adsorbent
HK1134296A1 (en) Fluoroalkyl phosphate compositions
ZA200807630B (en) Affinity Regions
HK1135989A1 (en) Polyfluoroether-based phosphates
GB2450462B (en) Refrigerant
HK1102230A1 (en) Iron
HK1108422A1 (en) Iron sulfate-based phosphate adsorbent
EP2039415A4 (en) DEHUMIFICATION / scavenger
GB0608042D0 (en) Steam iron
EP2123270A4 (en) MEANS TO IMPROVE THE IRON FLUID CHANGE
HK1130052A1 (en) Antitumoral dihydropyran-2-one compounds
HK1163730A1 (zh) 製冷劑組合物
HK1126514A1 (en) Refrigerant composition
PL2122041T3 (pl) Żelazko do prasowania
EP2055671A4 (en) METAL PHOSPHATE
GB0818424D0 (en) An iron
PL2025804T3 (pl) Żelazko
ZA200807386B (en) Refrigerant composition
GB0607013D0 (en) Brake block assembly
GB0604882D0 (en) Supported adsorbents
GB0622798D0 (en) Phosphorus compounds
GB0620836D0 (en) Steam iron
GB0611933D0 (en) Composite adsorbents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171212